Company

Wanbangde Receives FDA Feedback Endorsing Pivotal Phase III Path for WP205 Mecobalamin Injection in ALS
Clinical trial filingsRare / orphan disease drugs

Wanbangde Receives FDA Feedback Endorsing Pivotal Phase III Path for WP205 Mecobalamin Injection in ALS

Wanbangde Pharmaceutical Holding Group Co., Ltd. (WEPON) (SHE: 002082) announced that it has received written feedback from the U.S. Food and Drug Administration (FDA) regarding its plan to conduct a…

BMS Q3 Revenue Rises 7% to USD 13.1 Billion as Eliquis Surges 25% and Growth Portfolio Climbs 12%; Full‑Year Outlook Raised

BMS Q3 Revenue Rises 7% to USD 13.1 Billion as Eliquis Surges 25% and Growth Portfolio Climbs 12%; Full‑Year Outlook Raised

Sino Biopharmaceutical's CTTQ Partners with Revvity to Launch X‑Lab Joint Shared Laboratory for Antibody Drug R&D

Sino Biopharmaceutical’s CTTQ Partners with Revvity to Launch X‑Lab Joint Shared Laboratory for Antibody Drug R&D

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Pfizer and BioNTech's LP.8.1 COVID-19 Vaccine Gets EMA CHMP Nod
BioNTechCOVID-19

Pfizer and BioNTech’s LP.8.1 COVID-19 Vaccine Gets EMA CHMP Nod

Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification
CVDProduct approvals

Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification

Biogen's Zurzuvae Receives Positive CHMP Opinion for Postpartum Depression Treatment
BiogenMarket approval filings

Biogen’s Zurzuvae Receives Positive CHMP Opinion for Postpartum Depression Treatment

Sanofi's Sarclisa Approved in EU for Newly Diagnosed Multiple Myeloma
CancerNASDAQ: SNY

Sanofi’s Sarclisa Approved in EU for Newly Diagnosed Multiple Myeloma

Show More